Catalyst Wire Dossier Catalyst Wire Dossier

ZYPREXA RELPREVV

olanzapine pamoate · H2-Pharma LLC
Drug timelines are a Plus or Pro feature.

29 regulatory and trial events tracked for ZYPREXA RELPREVV, covering 2009-12-11 to 2026-01-30. Get the full timeline:

Most recent: FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)

See pricing